OR WAIT null SECS
© 2022 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2022 MJH Life Sciences™ and Formulary Watch. All rights reserved.
CAPSTONE HEALTH SERVICES FOUNDATION PC
850 5TH AVE E
January 17, 2022
The FDA okayed two Janus kinase 1 (JAK1) JAK inhibitors January 14 the for atopic dermatitis: Cibinqo and Rinvoq.
January 13, 2022
CMS has proposed covering the anti-amyloid treatment only if the person taking it is enrolled in a clinical trial.
January 07, 2022
January 03, 2022
A review of real-world data from Israel didn't show any increase risk of myocardities or pericarditis.
December 21, 2021
The FDA has set a Prescription Drug User Fee Act goal date of Sept. 28, 2022.
December 16, 2021
The broader indication for Zynrelef now covers around 7 million procedures annually and reduces the need for post-surgery opioids.